Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Iglarz

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Pharmacology|November 27, 1998
Chronic endothelin-1-induced changes in vascular reactivity in rat resistance arteries and aortaM Iglarz, B I Lévy, D Henrion
Arteriosclerosis, Thrombosis, and Vascular Biology|September 10, 1999
Chronic endothelin-1 improves nitric oxide-dependent flow-induced dilation in resistance arteries from normotensive and hypertensive ratsD Henrion, M Iglarz, B I Lévy
Journal of Cardiovascular Pharmacology|September 2, 1999
Prolonged blockade of endothelin ET(A) receptors decreases vascular reactivity in the aorta of spontaneously hypertensive rats in vitroM Iglarz, B I Lévy, D Henrion
Cardiovascular Research|December 23, 1998
Chronic blockade of endothelin ETA receptors improves flow dependent dilation in resistance arteries of hypertensive ratsM Iglarz, K Matrougui, B I Lévy, et al.
Life Sciences|April 25, 2012
Renal, retinal and cardiac changes in type 2 diabetes are attenuated by macitentan, a dual endothelin receptor antagonistS Sen, S Chen, B Feng, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|October 10, 1998
Determination of 2-n-propylquinoline in mouse plasma and liver by high-performance liquid chromatographyM Iglarz, B Baune, J C Gantier, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2001
Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-no pathwayM Iglarz, J S Silvestre, M Duriez, et al.
British Journal of Pharmacology|March 14, 2007
Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in ratsC De Ciuceis, F Amiri, M Iglarz, et al.
Clinical and Experimental Pharmacology & Physiology|June 12, 2004
Chronic decrease in flow contributes to heart failure-induced endothelial dysfunction in ratsC Devaux, M Iglarz, V Richard, et al.
Journal of Biological Regulators and Homeostatic Agents|July 9, 2013
Macitentan slows down the dermal fibrotic process in systemic sclerosis: in vitro findingsC Corallo, G Pecetti, M Iglarz, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Pharmacology|November 27, 1998
Chronic endothelin-1-induced changes in vascular reactivity in rat resistance arteries and aortaM Iglarz, B I Lévy, D Henrion
Arteriosclerosis, Thrombosis, and Vascular Biology|September 10, 1999
Chronic endothelin-1 improves nitric oxide-dependent flow-induced dilation in resistance arteries from normotensive and hypertensive ratsD Henrion, M Iglarz, B I Lévy
Journal of Cardiovascular Pharmacology|September 2, 1999
Prolonged blockade of endothelin ET(A) receptors decreases vascular reactivity in the aorta of spontaneously hypertensive rats in vitroM Iglarz, B I Lévy, D Henrion
Cardiovascular Research|December 23, 1998
Chronic blockade of endothelin ETA receptors improves flow dependent dilation in resistance arteries of hypertensive ratsM Iglarz, K Matrougui, B I Lévy, et al.
Life Sciences|April 25, 2012
Renal, retinal and cardiac changes in type 2 diabetes are attenuated by macitentan, a dual endothelin receptor antagonistS Sen, S Chen, B Feng, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|October 10, 1998
Determination of 2-n-propylquinoline in mouse plasma and liver by high-performance liquid chromatographyM Iglarz, B Baune, J C Gantier, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2001
Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-no pathwayM Iglarz, J S Silvestre, M Duriez, et al.
British Journal of Pharmacology|March 14, 2007
Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in ratsC De Ciuceis, F Amiri, M Iglarz, et al.
Clinical and Experimental Pharmacology & Physiology|June 12, 2004
Chronic decrease in flow contributes to heart failure-induced endothelial dysfunction in ratsC Devaux, M Iglarz, V Richard, et al.
Journal of Biological Regulators and Homeostatic Agents|July 9, 2013
Macitentan slows down the dermal fibrotic process in systemic sclerosis: in vitro findingsC Corallo, G Pecetti, M Iglarz, et al.
Pageof 2